[EN] SULPHONAMIDES AND COMPOSITIONS THEREOF FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY [FR] SULFONAMIDES ET COMPOSITIONS ASSOCIÉES POUR LE TRAITEMENT D'ÉTATS PATHOLOGIQUES ASSOCIÉS À UNE ACTIVITÉ DE NLRP
Rhodium-carbenoid mediated O-H insertion reactions. O-H insertion vs. H-abstraction and effect of catalyst
作者:Geoffrey G. Cox、David J. Miller、Christopher J. Moody、Eric-Robert H.B. Sie、Janusz J. Kulagowski
DOI:10.1016/s0040-4020(01)81117-0
日期:1994.3
The synthesis and rhodium mediated O-H insertion reactions of a wide range of diazo compounds are described. The rate at which the diazo compounds decompose in the presence of 2-propanol and the rhodium catalyst is strongly dependent on the electron withdrawing group(s) attached to the diazo carbon, with diazophosphonates being the least reactive. Insertion into the O-H bond of methanol, t-butanol
CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
申请人:Genentech, Inc.
公开号:EP3851434A1
公开(公告)日:2021-07-21
The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
Chemical compounds as inhibitors of interleukin-1 activity
申请人:Genentech, Inc.
公开号:US11040985B2
公开(公告)日:2021-06-22
The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.